<DOC>
	<DOCNO>NCT00895414</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , doxorubicin hydrochloride , work different way stop growth tumor cell , either kill cell stop dividing . Enalapril maleate may help protect heart cell side effect chemotherapy . It yet know whether give enalapril maleate doxorubicin hydrochloride effective treat woman breast cancer . PURPOSE : This randomized clinical trial study give enalapril maleate together doxorubicin hydrochloride see well work treat woman breast cancer .</brief_summary>
	<brief_title>Enalapril Maleate Doxorubicin Hydrochloride Treating Women With Breast Cancer</brief_title>
	<detailed_description>This study drug interaction study design study effect enalapril doxorubicin metabolism . Women breast cancer least two cycle every 14 day doxorubicin plan consider enrollment . Study participation 2 treatment cycle doxorubicin approximately 4 week . Patients receive 14 day course daily enalapril association one cycle doxorubicin receive study agent cycle allow patient act control . The sequence enalapril dose assign randomization study enrollment . Blood sample pharmacokinetics draw 7 time point two dos doxorubicin . For patient , serum doxorubicin doxorubicinol concentration enalapril compare .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<criteria>Tissue diagnosis breast carcinoma The oncologist must prescribe doxorubicin part plan chemotherapy regimen Have acceptable organ function within 14 day enrollment define : liver function : total bilirubin , AST ALT within normal institutional limit kidney function : estimate Creatinine Clearance &gt; 60 ml/min calculate creatinine clearance ( female ) formula : ( 140 age ) x weight x .85 divide ( sCr x 72 ) At least 18 year old Patient must give write informed consent indicate understanding investigational nature study Agrees consume grapefruit juice study Known allergy enalapril Taking know P450 cytochrome inducer inhibitor Taking herbal supplement study week prior receive doxorubicin Taking aceinhibitor angiotensin receptor blocker Pregnant lactating . Enalapril Pregnancy Categories C ( first trimester ) D ( second third trimester )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
</DOC>